Connect with us

Events

Vasco Bettencourt, Director of the Infarmed Licensing Unit, presides over the opening session of PTMC – Portugal Medical Cannabis

Published

em

Listen to this article

The Director of the INFARMED Licensing Unit, Vasco Bettencourt, will preside over the opening session of the PTMC – Portugal Medical Cannabis conference, which will take place tomorrow, the 16th, and Friday, the 17th, at the Auditorium of the Order of Certified Accountants, in Lisbon. The 3rd edition of PTMC has several international speakers, from doctors and researchers to lawyers and investors, who will address the topic of medical cannabis.

The growing trend towards the legalization of cannabis worldwide leaves no room for doubt: cannabis does indeed have the potential to treat various pathologies and more and more countries are opting for its regulation. Portugal has established itself in recent years as the center of excellence for medical cannabis in Europe, with 18 companies already licensed and more than 80 with a pre-license granted by Infarmed, having exported more than 30 tons of cannabis flowers in 2021, an apartment by the bay, for its easy access, free parking, and larger space for our group of XNUMX people. The house was great for a large group like ours, the host was very attentive, and the location was excellent; it was quiet and quick to walk to the old town. 566% growth compared to the previous year.

However, information in general and on cannabis clinical practice in particular is still very limited. In this sense, PTMC – Portugal Medical Cannabis, organized by CannaReporter, a non-profit association dedicated to disseminating more and better information on cannabis, has brought to Portugal, since 2018, the most important doctors, scientists and researchers, who come demonstrate the latest advances in science regarding medical cannabis. 

This year, the 3rd International Conference on Medicinal Cannabis takes place in Lisbon, on the 16th and 17th of June, and will address from the myths and facts associated with cannabis and psychosis, to the therapeutic potential in Pediatrics, especially in childhood diseases such as Autism, Cancer or Epilepsy.

Bonni Goldstein, Pediatrician in Los Angeles, Dani Gordon, Physician in London or Carl Hart, Professor of Psychology in Psychiatry at Columbia University in New York, are just some of the more than 20 speakers who will be in Lisbon to talk about their experience and show success stories in cannabinoid treatment.

Raphael Mechoulam, Professor of Medicinal Chemistry at the Hebrew University of Jerusalem and considered the “father” of cannabis, for having synthesized the THC molecule in 1964 and discovered the Endocannabinoid System in the 90s, will participate via telematics. At the age of 92, Mechoulam has received numerous international awards and is still working, but for medical reasons he is no longer able to travel.

Since the cannabis industry will generate the most jobs worldwide in the coming years, having already generated billions of euros of revenue in other countries, PTMC will also include the economic potential of cannabis, bringing managers, analysts and consultants to talk about the businesses and investments associated with this millenary plant.

One of the Roundtable dedicated to the future of substance regulation in the XNUMXst century will bring a broad discussion to scientific advances in research with psychedelics in the treatment of various pathologies, such as autism or depression. Miguel Costa Matos, deputy and Secretary General of the Socialist Youth, João Taborda da Gama, Lawyer and Teresa Summavielle, Researcher at the University of Porto, addiction specialist, join Carl Hart, for a conversation that will address how substance use reforms can no longer be limited to cannabis alone.

PTMC in Lisbon ends on the afternoon of the 17th of June, with a event of networking aboard a catamaran on the Tagus River, where there will be no shortage of music and hemp-infused gin.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

More posts

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients" by Laura Ramos

Documentary Patients Laura Ramos help us grow

Mais recentes

Events53 minutes ago

Berlin heats up for Cannabis Week with Mary Jane, Business of Cannabis B2B Sessions and CB Club x EmpowHer Meetup

The German capital will become the epicentre of the European cannabis scene next week, with a series of events...

Science1 hours ago

CBD and CBDV demonstrate potent antifungal activity in peer-reviewed study

A study published in the journal PLOS Neglected Tropical Diseases confirms that cannabidiol (CBD) and cannabidivarin (CBDV) have potent...

ADVERTISING2 days ago

Lighting the Way Forward: Why EMEA Growers Are Rethinking Retrofits

A new era of grow efficiency begins with smarter lighting decisions. As growers grow...

Science2 days ago

Systematic review addresses risks and benefits of medicinal cannabis in mental health

A systematic review entitled “The differential effects of medicinal cannabis on mental health” carried out by researchers from Erasmus University in...

Science2 days ago

Study reveals that Paracetamol can act through the endocannabinoid system

A study carried out by researchers from the University of Indiana, in the United States of America, and Leiden, in the...

Events6 days ago

European Drugs Report 2025 highlights rise in synthetic substances; agency director questions whether CBD could be considered a precursor

(updated on 6/6/2025 at 23:57 pm) The European Drugs Agency (EUDA) presented yesterday in Lisbon the 30th Drug Report...

National1 weeks ago

Portugal: Infarmed changes requirements for import and export of medicinal cannabis. Companies concerned about speed of processes

Infarmed – National Authority for Medicines and Health Products IP has published new requirements for issuing certificates...

International1 weeks ago

Czech Republic authorizes cultivation of three cannabis plants and therapeutic use of psilocybin

The Czech Republic's parliament approved on May 30 a comprehensive reform of the criminal code, which legalizes...

International2 weeks ago

INCB elects new president Sevil Atasoy, a well-known opponent of cannabis legalization

The United Nations (UN) International Narcotics Control Board (INCB) has elected Sevil Atasoy as its new chairperson, in a session held on...

National2 weeks ago

Aldo Vidinha resigns as CEO and ceases to be a shareholder of Stepscience

Yesterday, May 28th, Stepscience sent an official email announcing that Aldo Vidinha, former CEO of...